Tiantian Zou

1.7k citations
29 papers · 1.2k indexed · 1 hit paper · h-index 15

Tiantian Zou

26 papers receiving 1.2k citations

Hit Papers

Isolation and characterization of exosomes for cancer res...3762020202620222024100200300

Peers

Tiantian Zou
Comparison fields: 5 of 103
  • Cancer Research 507
  • Hepatology 174
  • Molecular Biology 683
  • Epidemiology 258
  • Immunology 148
Replace Yang-Hsiang Lin with:
Yang-Hsiang Lin Taiwan
Mingxuan Feng China
Cécile Devue France
Sunbin Ling China
Genshu Wang China
Stratigoula Sakellariou Greece
Yaojie Fu United States
Shuichi Iwahashi Japan
Jack Leslie United Kingdom
Yingmin Yao China
Tiantian Zou relative to Yang-Hsiang Lin Taiwan Yang-Hsiang Lin's profile →
Citations per field
00.5×3.0×
Yang-Hsiang Lin · 1×
Citations per year

Countries citing papers authored by Tiantian Zou

Since Specialization
Citations

This map shows the geographic impact of Tiantian Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiantian Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiantian Zou more than expected).

Fields of papers citing papers by Tiantian Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiantian Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiantian Zou. The network helps show where Tiantian Zou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tiantian Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tiantian Zou Line = papers co-authored together Tiantian Zou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202442
3 202414
4 202421
5 20240
6 2022104
7 20223
8 202212
9 20223
10 20212
11
Isolation and characterization of exosomes for cancer researchbreakdown →
2020376
12 202024
13 201846
14 201710
15 20174
16 201713
17 201722
18 20178
19 201662
20 201624

About Tiantian Zou

Tiantian Zou is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (4 papers), Cancer, Lipids, and Metabolism (3 papers), Diet, Metabolism, and Disease (3 papers), Ferroptosis and cancer prognosis (3 papers), Cardiac Ischemia and Reperfusion (3 papers), Extracellular vesicles in disease (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Cancer Research (507 citations), Hepatology (174 citations) and Molecular Biology (683 citations). Tiantian Zou has collaborated with scholars based in China, Belgium and United Kingdom. Frequent co-authors include Lun–Xiu Qin, Qiongzhu Dong, Yan Zheng, Yan Fu, Xiaotian Shen, Beiyuan Hu, Ming‐Hua Zheng, Haoting Sun, Le Zhu and Ji-Na Zheng. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026